Literature DB >> 25449474

Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.

Haiyan Xu1, Xiongwei Xie2, Bingjian Wang2, Yu Chen2, Tao Meng2, Shuren Ma2, Fang Wang3.   

Abstract

Entities:  

Keywords:  CYP2C9; Meta analysis; Pharmacogenetics; VKORC1; Warfarin

Mesh：

Substances：

Year:  2014        PMID： 25449474     DOI： 10.1016/j.ijcard.2014.09.174

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.

Authors:  Letícia C Tavares; Nubia E Duarte; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo Caleb Junior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2018-07-26       Impact factor: 2.953

2.  Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary Tse; Mengqi Gong; Guangping Li; Sunny Hei Wong; William K K Wu; Wing Tak Wong; Leonardo Roever; Alex Pui Wai Lee; Gregory Y H Lip; Martin C S Wong; Tong Liu
Journal:  Br J Clin Pharmacol       Date:  2018-06-21       Impact factor: 4.335

Review 3.  Precision dosing of warfarin: open questions and strategies.

Authors:  Xi Li; Dan Li; Ji-Chu Wu; Zhao-Qian Liu; Hong-Hao Zhou; Ji-Ye Yin
Journal:  Pharmacogenomics J       Date:  2019-02-12       Impact factor: 3.550

4.  Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease.

Authors:  Laith N Al-Eitan; Barakat Z Elsaqa; Ayah Y Almasri; Hatem A Aman; Rame H Khasawneh; Mansour A Alghamdi
Journal:  Pharmgenomics Pers Med       Date:  2020-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.